Why These Stocks Are Worth The Pain
When it comes to this group of stocks, Shark Tank’s Kevin O’Leary argues it’s a big mistake not to own them – even though doing… Read More »Why These Stocks Are Worth The Pain
Stocks to Watch
A Dope Trade Setup
With FANG stocks lagging, cannabis stocks have become the true momentum play for day traders – and most dope stocks appear to be lined up… Read More »A Dope Trade Setup
Pot Stock Shift: From Canadian LPs to U.S. MSOs
If licensed producers in Canada dominated the marijuana scene in 2018, a different group of pot plays may be poised to dominate in 2019: multi-state… Read More »Pot Stock Shift: From Canadian LPs to U.S. MSOs
Biotech’s 2019 “Plot Twist”
After a rough end to 2018, with massive fund outflows in the fourth quarter, biotech’s condition has been improving in 2019 – and these two… Read More »Biotech’s 2019 “Plot Twist”
Locating The Real Opportunity In Small Caps
Small caps have started 2019 off strong, and they may be impossible for investors to ignore going forward. European small caps, that is. CLICK HERE.
This New ETF Is All About Disruption
Fintech is one of the big buzzwords these days, referring to innovative technologies that seek to improve and automate the delivery of financial services. And… Read More »This New ETF Is All About Disruption
Mining Opportunity In Palladium’s Surge
Palladium has been the best-performing commodity for two years straight, with the price of the precious metal even recently surpassing that of gold for the… Read More »Mining Opportunity In Palladium’s Surge
The Driverless Car Detour
As the next step in the driverless car revolution nears, many automakers are backing away from it. Here’s why – and which automaker stocks may… Read More »The Driverless Car Detour
Investing With One Of The Street’s Most Influential Women
She is one of the most influential women on Wall Street and the visionary behind Ellevest, the first ever digital investment platform for women. Here’s… Read More »Investing With One Of The Street’s Most Influential Women
Therapeutic Trifecta
With a promising cannabinoid pipeline, an alternative to the EpiPen, and a superior solution for opioid overdoses, this firm has moved in on not one… Read More »Therapeutic Trifecta